Gemma Barroso García

Mrs. Gemma Barroso García

orcid
Proteomics Facility (HNP)

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AAAngel Arevalo-Martin
Angel Arevalo-Martin
LGLukas Grassner
Lukas Grassner
DGDaniel Garcia-Ovejero
Daniel Garcia-Ovejero
BPBeatriz Paniagua-Torija
Beatriz Paniagua-Torija
GGGemma Barroso García
Gemma Barroso García
EMEduardo Molina-Holgado
Eduardo Molina-Holgado
Spinal cord injury (SCI) results in long-term neurological and systemic consequences, including antibody-mediated autoimmunity, which has been related to impaired functional recovery. Here we show that autoantibodies that increase at the subacute phase of human SCI, 1 month after lesion, are already present in healthy subjects and directed against non-native proteins rarely present in the normal spinal cord. The increase of these autoantibodies is a fast phenomenon–their levels are already elevated before 5 days after lesion–characteristic of secondary immune responses, further supporting their origin as natural antibodies. By proteomics studies we have identified that the increased autoantibodies are directed against 16 different nervous system and systemic self-antigens related to changes known to occur after SCI, including alterations in neural cell cytoskeleton, metabolism and bone remodeling. Overall, in the context of previous studies, our results offer an explanation to why autoimmunity develops after SCI and identify novel targets involved in SCI pathology that warrant further investigation.

10 February 1997 in Helvetica Chimica Acta
Verified
Journal Article
Closed access
PDF file
JRJuan Carlos Rodriguez‐Ubis
Juan Carlos Rodriguez‐Ubis
RSRosa Sedano
Rosa Sedano
GGGemma Barroso García
Gemma Barroso García
OJOlga Juanes
Olga Juanes
EBErnesto Brunet
Ernesto Brunet

1 January 2010 in Clinical Medicine Insights: Cardiology
Verified
Journal Article
Open access
FGFelix Gil-Dones
Felix Gil-Dones
TRTatiana Martin Rojas
Tatiana Martin Rojas
LLLuis F. Lopez-Almodovar
Luis F. Lopez-Almodovar
Fernando de la CuestaFernando de la Cuesta
Fernando de la Cuesta
VDVeronica M. Darde
Veronica M. Darde
María G BarderasMaría G Barderas
María G Barderas
Calcified aortic valve disease is a slowly progressive disorder that ranges from mild valve thickening with no obstruction of blood flow, known as aortic sclerosis, to severe calcification with impaired leaflet motion or aortic stenosis. In the present work we describe a rapid, reproducible and effective method to carry out proteomic analysis of stenotic human valves by conventional 2-DE and 2D-DIGE, minimizing the interference due to high calcium concentrations. Furthermore, the protocol permits the aortic stenosis proteome to be analysed, advancing our knowledge in this area. Until recently, aortic stenosis (AS) was considered a passive process secondary to calcium deposition in the aortic valves. However, it has recently been highlighted that the risk factors associated with the development of calcified AS in the elderly are similar to those of coronary artery disease. Furthermore, degenerative AS shares histological characteristics with atherosclerotic plaques, leading to the suggestion that calcified aortic valve disease is a chronic inflammatory process similar to atherosclerosis. Nevertheless, certain data does not fit with this theory making it necessary to further study this pathology. The aim of this study is to develop an effective protein extraction protocol for aortic stenosis valves such that proteomic analyses can be performed on these structures. In the present work we have defined a rapid, reproducible and effective method to extract proteins and that is compatible with 2-DE, 2D-DIGE and MS techniques. Defining the protein profile of this tissue is an important and challenging task that will help to understand the mechanisms of physiological/pathological processes in aortic stenosis valves.

1 January 2017 in Neuroscience
Verified
Journal Article
Closed access
WPWolfgang Pita-Thomas
Wolfgang Pita-Thomas
GGGemma Barroso García
Gemma Barroso García
VMVeronica Moral
Veronica Moral
AHAmber R. Hackett
Amber R. Hackett
VCValeria Cavalli
Valeria Cavalli
MNManuel Nieto-Diaz
Manuel Nieto-Diaz

1 January 2009 in Biomarker Insights
Verified
Journal Article
Open access
FGF. Gil-Dones
F. Gil-Dones
SAS. Alonso-Orgaz
S. Alonso-Orgaz
GAG. Avila
G. Avila
TRTatiana Martin Rojas
Tatiana Martin Rojas
VMV. Moral-Darde
V. Moral-Darde
María G BarderasMaría G Barderas
María G Barderas
Since the function of the spinal cord depends on the proteins found there, better defing the normal Spinal Cord Proteome is an important and challenging task. Although brain and cerebrospinal fluid samples from patients with different central nervous system (CNS) disorders have been studied, a thorough examination of specific spinal cord proteins and the changes induced by injury or associated to conditions such as neurodegeneration, spasticity and neuropathies has yet to be performed. In the present study, we aimed to describe total protein content in the spinal cord of healthy rats, employing different proteomics tools. Accordingly, we have developed a fast, easy, and reproducible sequential protocol for protein extraction from rat spinal cords. We employed conventional two dimensional electrophoresis (2DE) in different pH ranges (eg. 4–7, 3–11 NL) combined with identification by mass spectrometry (MALDI-TOF/TOF), as well as first dimension protein separation combined with Liquid Chromatography Mass Spectrometry/Mass Spectrometry (LC-MS/MS) to maximise the benefits of this technology. The value of these techniques is demonstrated here by the identification of several proteins known to be associated with neuroglial structures, neurotransmission, cell survival and nerve growth in the central nervous system. Furthermore this study identified many spinal proteins that have not previously been described in the literature and which may play an important role as either sensitive biomarkers of dysfunction or of recovery after Spinal Cord Injury.

9 April 2022 in Cells
Verified
Journal Article
Open access
PDF file
MMMario Martínez-Torija
Mario Martínez-Torija
PEPedro Esteban
Pedro Esteban
FEFrancisco Javier Espino-Rodríguez
Francisco Javier Espino-Rodríguez
BPBeatriz Paniagua-Torija
Beatriz Paniagua-Torija
EMEduardo Molina-Holgado
Eduardo Molina-Holgado
RMRafael Moreno-Luna
Rafael Moreno-Luna
The risk of complications following surgical procedures is significantly increased in patients with SARS-CoV-2 infection. However, the mechanisms underlying these correlations are not fully known. Spinal cord injury (SCI) patients who underwent reconstructive surgery for pressure ulcers (PUs) before and during the COVID-19 pandemic were included in this study. The patient’s postoperative progression was registered, and the subcutaneous white adipose tissue (s-WAT) surrounding the ulcers was analyzed by proteomic and immunohistochemical assays to identify the molecular/cellular signatures of impaired recovery. Patients with SCI and a COVID-19-positive diagnosis showed worse recovery and severe postoperative complications, requiring reintervention. Several proteins were upregulated in the adipose tissue of these patients. Among them, CKMT2 and CKM stood out, and CKM increased for up to 60 days after the COVID-19 diagnosis. Moreover, CKMT2 and CKM were largely found in MGCs within the s-WAT of COVID patients. Some of these proteins presented post-translational modifications and were targeted by autoantibodies in the serum of COVID patients. Overall, our results indicate that CKMT2, CKM, and the presence of MGCs in the adipose tissue surrounding PUs in post-COVID patients could be predictive biomarkers of postsurgical complications. These results suggest that the inflammatory response in adipose tissue may underlie the defective repair seen after surgery.